Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.31264 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.297 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.57101 | 79 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.46277 | 78 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.24093 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.18762 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.29036 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.22603 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.53617 | 79 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.28646 | 77 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.2808 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.27162 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.28164 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.28399 | 77 |